ATE250054T1 - Oxazolidinone derivate und pharmazeutische zusammensetzungen - Google Patents

Oxazolidinone derivate und pharmazeutische zusammensetzungen

Info

Publication number
ATE250054T1
ATE250054T1 AT98956200T AT98956200T ATE250054T1 AT E250054 T1 ATE250054 T1 AT E250054T1 AT 98956200 T AT98956200 T AT 98956200T AT 98956200 T AT98956200 T AT 98956200T AT E250054 T1 ATE250054 T1 AT E250054T1
Authority
AT
Austria
Prior art keywords
pharmaceutical compositions
oxazolidinone derivatives
organisms
compound
formula
Prior art date
Application number
AT98956200T
Other languages
English (en)
Inventor
Jackson B Hester Jr
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE250054T1 publication Critical patent/ATE250054T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT98956200T 1997-11-12 1998-10-30 Oxazolidinone derivate und pharmazeutische zusammensetzungen ATE250054T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6537697P 1997-11-12 1997-11-12
PCT/US1998/022639 WO1999024428A1 (en) 1997-11-12 1998-10-30 Oxazolidinone derivatives and pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE250054T1 true ATE250054T1 (de) 2003-10-15

Family

ID=22062294

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98956200T ATE250054T1 (de) 1997-11-12 1998-10-30 Oxazolidinone derivate und pharmazeutische zusammensetzungen

Country Status (21)

Country Link
US (1) US5998406A (de)
EP (1) EP1030852B1 (de)
JP (1) JP2001522849A (de)
KR (1) KR20010031953A (de)
CN (1) CN1154644C (de)
AT (1) ATE250054T1 (de)
AU (1) AU739055B2 (de)
BR (1) BR9813985A (de)
CA (1) CA2303959A1 (de)
DE (1) DE69818294T2 (de)
DK (1) DK1030852T3 (de)
ES (1) ES2207010T3 (de)
HU (1) HUP0100470A3 (de)
IL (1) IL136062A (de)
NO (1) NO317291B1 (de)
NZ (1) NZ504503A (de)
PT (1) PT1030852E (de)
RU (1) RU2215740C2 (de)
SK (1) SK284577B6 (de)
TR (1) TR200001330T2 (de)
WO (1) WO1999024428A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1311787A (zh) 1998-06-05 2001-09-05 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及含有它们的药物组合物
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
KR100355345B1 (ko) * 2000-01-21 2002-10-12 한국과학기술연구원 티오펜환을 함유한 신규한 옥사졸리디논 유도체, 그의 제조방법 및 조성물
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE60304360T2 (de) * 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
DE10300111A1 (de) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
JP2007503426A (ja) * 2003-08-25 2007-02-22 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 新規な抗微生物性アリールオキサゾリジノン化合物
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
KR100854211B1 (ko) 2003-12-18 2008-08-26 동아제약주식회사 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물
WO2006056877A2 (en) * 2004-11-29 2006-06-01 Pharmacia & Upjohn Company Llc Diazepine oxazolidinones as antibacterial agents
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (de) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prophylaxe und Behandlung von thrombolischen Erkrankungen
CA2610978A1 (en) 2005-06-29 2007-01-04 Pharmacia & Upjohn Company Llc Homomorpholine oxazolidinones as antibacterial agents
DE102005045518A1 (de) * 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
CA2823159C (en) 2005-10-04 2014-10-21 Bayer Intellectual Property Gmbh Polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102005047558A1 (de) * 2005-10-04 2008-02-07 Bayer Healthcare Ag Kombinationstherapie substituierter Oxazolidinone zur Prophylaxe und Behandlung von cerebralen Durchblutungsstörungen
EP2181993A1 (de) 2006-03-31 2010-05-05 Research Foundation Itsuu Laboratory Antimikrobielle Oxazolidinonderivate
CN101883768A (zh) * 2007-10-02 2010-11-10 财团法人乙卯研究所 具有7元杂环的噁唑烷酮衍生物
EP2635589A1 (de) 2010-11-03 2013-09-11 Wockhardt Limited Verfahren zur herstellung von phosphorsäure-mono- l- {[4- (s) -5- (acetylaminomethyl) - 2 - oxo - oxazolidin- - 3 yl] - 2, 6 -} difluorphenyl - 4 - methoxymethylpiperidin- 4 - yl)-ester
WO2015173664A1 (en) 2014-05-14 2015-11-19 Wockhardt Limited Process for the preparation of (5s)-n-{3-[3,5-difluoro-4-(4-hydroxy-4-methoxymethyl-piperidin-1-yl)-phenyl]-2-oxo-oxazolidin-5-ylmethyl}-acetamide

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
CA1317594C (en) * 1987-10-21 1993-05-11 Chung-Ho Park Aminomethyloxooxazolidinyl ethenylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
WO1990002744A1 (en) * 1988-09-15 1990-03-22 The Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones
ATE146783T1 (de) * 1991-11-01 1997-01-15 Upjohn Co Substituierte aryl- und heteroaryl- phenyloxazolidinone
SK283420B6 (sk) * 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
WO1995014684A1 (en) * 1993-11-22 1995-06-01 The Upjohn Company Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones
JPH0873455A (ja) * 1994-03-15 1996-03-19 Upjohn Co:The オキサゾリジノン誘導体及びこれを有効成分とする医薬組成物
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds

Also Published As

Publication number Publication date
NO20002434D0 (no) 2000-05-11
CN1154644C (zh) 2004-06-23
DK1030852T3 (da) 2003-12-22
TR200001330T2 (tr) 2000-11-21
JP2001522849A (ja) 2001-11-20
CA2303959A1 (en) 1999-05-20
US5998406A (en) 1999-12-07
IL136062A0 (en) 2001-05-20
NO317291B1 (no) 2004-10-04
DE69818294D1 (de) 2003-10-23
SK284577B6 (sk) 2005-07-01
CN1271358A (zh) 2000-10-25
BR9813985A (pt) 2000-09-26
WO1999024428A1 (en) 1999-05-20
NZ504503A (en) 2002-10-25
NO20002434L (no) 2000-05-11
HK1030373A1 (en) 2001-05-04
HUP0100470A3 (en) 2002-08-28
AU1277899A (en) 1999-05-31
AU739055B2 (en) 2001-10-04
EP1030852B1 (de) 2003-09-17
ES2207010T3 (es) 2004-05-16
HUP0100470A2 (hu) 2002-05-29
PT1030852E (pt) 2004-02-27
EP1030852A1 (de) 2000-08-30
SK6182000A3 (en) 2000-12-11
DE69818294T2 (de) 2004-07-08
KR20010031953A (ko) 2001-04-16
RU2215740C2 (ru) 2003-11-10
IL136062A (en) 2004-02-08

Similar Documents

Publication Publication Date Title
DE69818294D1 (de) Oxazolidinone derivate und pharmazeutische zusammensetzungen
ATE232862T1 (de) Oxazolidinon derivate und diese enthaltende pharmazeutische zusammensetzungen
SE9604786D0 (sv) New compounds
NO996269L (no) Kinolin-indol antimikrobielle midler, samt anvendelse og blandinger derav
ATE248837T1 (de) Chinuclidin-acrylamide
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
TR200102042T2 (tr) Spiro fropiridinlerin, tedavide faydalı yeni aralkil aminleri.
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
PA8451801A1 (es) Derivados de la 9-oxima eritromicina
ATE194987T1 (de) Substituierte dibenzoxazepinverbindungen, pharmazeutische zusammensetzungen und anwendungsmethoden
NZ333926A (en) Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use
CA2386685A1 (en) Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
ATE203246T1 (de) Dialkyltiacumicine
ATE141605T1 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische anwendungen
BR0309878A (pt) Heterotriciclil-6-alquilideno-penemas como inibidores de beta-lactamase
ATE250610T1 (de) Kaliumkanal-blockierende mittel
TR200200485T2 (tr) Yeni A-500359 türevleri.
KR970703147A (ko) 동맥경화 억제제(Arteriosclerosis Depressant)
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
NZ503027A (en) Use of rifamycin derivative for treating mastitis in a domestic animal
BR9908452A (pt) Composição fungicida que compreende uma benzoilfeniluréia
TR199700921T1 (xx) �nsanlarda g�r�len herpes-vir�s-8'in tedavisinde pensiklovir'in kullan�lmas�.
ATE182883T1 (de) Therapeutische benzonitrile
UA30143C2 (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1030852

Country of ref document: EP

REN Ceased due to non-payment of the annual fee